loadpatents
name:-0.08713698387146
name:-0.053729057312012
name:-0.026869058609009
PONS; Jaume Patent Filings

PONS; Jaume

Patent Applications and Registrations

Patent applications and USPTO patent grants for PONS; Jaume.The latest application filed is for "methods of treating cancer".

Company Profile
23.56.80
  • PONS; Jaume - San Francisco CA
  • Pons; Jaume - San Carlos CA
  • Pons; Jaume - San Bruno CA
  • Pons; Jaume - South San Francisco CA
  • Pons; Jaume - East Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Of Treating Cancer
App 20220242928 - PONS; Jaume ;   et al.
2022-08-04
Antibodies against signal-regulatory protein alpha and methods of use
Grant 11,401,338 - Pons , et al. August 2, 2
2022-08-02
Heterodimeric proteins and methods for producing and purifying them
Grant 11,390,689 - Ho , et al. July 19, 2
2022-07-19
Methods Of Treating Cancer
App 20220213166 - PONS; Jaume ;   et al.
2022-07-07
Multimers For Reducing The Interference Of Drugs That Bind Cd47 In Serological Assays
App 20220196651 - PONS; Jaume ;   et al.
2022-06-23
Sap Fc Fusion Proteins And Methods Of Use
App 20220160831 - PONS; Jaume
2022-05-26
Antibodies against signal-regulatory protein .alpha. and methods of use
Grant 11,292,850 - Pons , et al. April 5, 2
2022-04-05
Immunomodulating Polynucleotide Conjugates And Methods Of Use
App 20220096649 - PONS; Jaume ;   et al.
2022-03-31
Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
App 20220056114 - Zeller; Joerg ;   et al.
2022-02-24
Antibodies against signal-regulatory protein alpha and methods of use
Grant 11,242,404 - Pons , et al. February 8, 2
2022-02-08
Antibodies Against Signal-regulatory Protein Alpha And Methods Of Use
App 20220002434 - PONS; Jaume ;   et al.
2022-01-06
Constructs having a SIRP-alpha domain or variant thereof
Grant 11,208,459 - Pons , et al. December 28, 2
2021-12-28
Sirp-alpha Variant Constructs And Uses Thereof
App 20210388329 - DEMING; Laura ;   et al.
2021-12-16
Antibodies Against Signal-regulatory Protein Alpha And Methods Of Use
App 20210363269 - PONS; Jaume ;   et al.
2021-11-25
Decoy Polypeptides
App 20210347848 - SIM; Bang Janet ;   et al.
2021-11-11
Polyethylenimine (PEI)-polypeptide conjugates and methods of use thereof
Grant 11,103,589 - Trias , et al. August 31, 2
2021-08-31
Combination Therapies For Treating Cancer
App 20210154269 - WAN; Hong ;   et al.
2021-05-27
Anti-NGF antibodies and methods using same
Grant 11,008,386 - Pons , et al. May 18, 2
2021-05-18
Engineered Polypeptide Conjugates And Methods For Making Thereof Using Transglutaminase
App 20210115159 - STROP; Pavel ;   et al.
2021-04-22
Constructs Having A Sirp-alpha Domain Or Variant Thereof
App 20210070838 - PONS; Jaume ;   et al.
2021-03-11
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
Grant 10,941,216 - Strop , et al. March 9, 2
2021-03-09
Methods And Reagents For Reducing The Interference Of Drugs That Bind Cd47 In Serological Assays
App 20200400662 - WAN; Hong ;   et al.
2020-12-24
Methods Of Treating Cancer
App 20200392199 - PONS; Jaume ;   et al.
2020-12-17
Sirp-alpha Variant Constructs And Uses Thereof
App 20200263154 - DEMING; Laura ;   et al.
2020-08-20
Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
App 20200247878 - Kind Code
2020-08-06
Constructs Having A Sirp-alpha Domain Or Variant Thereof
App 20200239543 - PONS; Jaume ;   et al.
2020-07-30
Constructs having a SIRP-alpha domain or variant thereof
Grant 10,696,730 - Pons , et al. June 30, 2
2020-06-30
Activatable Antibodies And Methods Of Use Thereof
App 20200062851 - VRLJIC; Marija ;   et al.
2020-02-27
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
App 20200024366 - PONS; Jaume ;   et al.
2020-01-23
Antibodies Against Signal-regulatory Protein Alpha And Methods Of Use
App 20190352419 - PONS; Jaume ;   et al.
2019-11-21
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
Grant 10,329,343 - Zeller , et al.
2019-06-25
Constructs Having A Sirp-alpha Domain Or Variant Thereof
App 20190169266 - PONS; Jaume ;   et al.
2019-06-06
Constructs having a SIRP-.alpha. domain or variant thereof
Grant 10,259,859 - Pons , et al.
2019-04-16
Heterodimeric Proteins And Methods For Producing And Purifying Them
App 20190100603 - HO; Weihsien ;   et al.
2019-04-04
Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same
App 20190092841 - Zeller; Joerg ;   et al.
2019-03-28
Polyethylenimine (pei)-polypeptide Conjugates And Methods Of Use Thereof
App 20190091341 - TRIAS; Joaquim ;   et al.
2019-03-28
Sirp-alpha Variant Constructs And Uses Thereof
App 20180371435 - DEMING; Laura ;   et al.
2018-12-27
Heterodimeric proteins and methods for producing and purifying them
Grant 10,138,303 - Ho , et al. Nov
2018-11-27
Methods For Treating Headache Using Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide
App 20180162931 - Zeller; Joerg ;   et al.
2018-06-14
Antibodies Against Signal-regulatory Protein Alpha And Methods Of Use
App 20180105600 - PONS; Jaume ;   et al.
2018-04-19
Antagonist antibodies directed against calcitonin gene-related peptide
Grant 9,890,210 - Zeller , et al. February 13, 2
2018-02-13
Antagonist antibodies directed against calcitonin gene-related peptide
Grant 9,890,211 - Zeller , et al. February 13, 2
2018-02-13
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
Grant 9,884,907 - Zeller , et al. February 6, 2
2018-02-06
Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide
Grant 9,884,908 - Zeller , et al. February 6, 2
2018-02-06
Anti-ngf Antibodies And Methods Using Same
App 20170342143 - PONS; Jaume ;   et al.
2017-11-30
Engineered Polypeptide Conjugates And Methods For Making Thereof Using Transglutaminase
App 20170313787 - STROP; Pavel ;   et al.
2017-11-02
Antagonist Antibodies Directed Against Calcitonin Gene- Related Peptide
App 20170240623 - Zeller; Joerg ;   et al.
2017-08-24
Antagonist Antibodies Directed Against Calcitonin Gene- Related Peptide
App 20170240622 - Zeller; Joerg ;   et al.
2017-08-24
Antagonist Antibodies Directed Against Calcitonin Gene- Related Peptide
App 20170240625 - Zeller; Joerg ;   et al.
2017-08-24
Antagonist Antibodies Directed Against Calcitonin Gene- Related Peptide
App 20170240624 - Zeller; Joerg ;   et al.
2017-08-24
Anti-NGF antibodies and methods using same
Grant 9,708,398 - Pons , et al. July 18, 2
2017-07-18
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
Grant 9,676,871 - Strop , et al. June 13, 2
2017-06-13
Constructs Having A Sirp-alpha Domain Or Variant Thereof
App 20170107270 - PONS; Jaume ;   et al.
2017-04-20
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20170081395 - Zeller; Joerg ;   et al.
2017-03-23
Heterodimeric Proteins And Methods For Producing And Purifying Them
App 20170058054 - HO; Weihsien ;   et al.
2017-03-02
Heterodimeric proteins and methods for producing and purifying them
Grant 9,527,926 - Ho , et al. December 27, 2
2016-12-27
Sirp-alpha Variant Constructs And Uses Thereof
App 20160319256 - Deming; Laura ;   et al.
2016-11-03
Sirp-alpha Variant Constructs And Uses Thereof
App 20160186150 - Deming; Laura ;   et al.
2016-06-30
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20160168244 - Zeller; Joerg ;   et al.
2016-06-16
Methods of using anti-CGRP antagonist antibodies
Grant 9,365,648 - Zeller , et al. June 14, 2
2016-06-14
Anti-ngf Antibodies And Methods Using Same
App 20160152698 - PONS; Jaume ;   et al.
2016-06-02
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
Grant 9,346,881 - Zeller , et al. May 24, 2
2016-05-24
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
Grant 9,340,614 - Zeller , et al. May 17, 2
2016-05-17
Methods of using anti-CGRP antagonist antibodies
Grant 9,328,168 - Zeller , et al. May 3, 2
2016-05-03
Pc33718e
App 20160096898 - LIANG; Hong ;   et al.
2016-04-07
Antibodies Directed Against Amyloid-beta Peptide And Methods Using Same
App 20160096884 - ROSENTHAL; Arnon ;   et al.
2016-04-07
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
Grant 9,266,951 - Zeller , et al. February 23, 2
2016-02-23
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20150361171 - Zeller; Joerg ;   et al.
2015-12-17
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20150361172 - Zeller; Joerg ;   et al.
2015-12-17
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20150361173 - Zeller; Joerg ;   et al.
2015-12-17
Anti-NGF antibodies and methods using same
Grant 9,212,222 - Pons , et al. December 15, 2
2015-12-15
PCSK9 antagonists
Grant 9,175,093 - Liang , et al. November 3, 2
2015-11-03
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20150291690 - Zeller; Joerg ;   et al.
2015-10-15
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
App 20150266974 - PONS; Jaume ;   et al.
2015-09-24
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
Grant 9,115,194 - Zeller , et al. August 25, 2
2015-08-25
Anti-PCSK9 antibodies with pH dependent antigen binding
Grant 9,029,515 - Pons , et al. May 12, 2
2015-05-12
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20150050267 - Zeller; Joerg ;   et al.
2015-02-19
Anti-ngf Antibodies And Methods Using Same
App 20150050286 - PONS; JAUME ;   et al.
2015-02-19
Methods Of Treating Vasomotor Symptoms Using Antibodies
App 20140147438 - ZELLER; JOERG ;   et al.
2014-05-29
Methods of treating vasomotor symptoms using antibodies
Grant 8,734,802 - Zeller , et al. May 27, 2
2014-05-27
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
Grant 8,597,649 - Zeller , et al. December 3, 2
2013-12-03
Antibodies specific for DKK-1 and their uses
Grant 8,586,721 - Paralkar , et al. November 19, 2
2013-11-19
Methods of using anti-CGRP antagonist antibodies
Grant 8,586,045 - Zeller , et al. November 19, 2
2013-11-19
Pcsk9 Antagonists
App 20130273069 - LIANG; Hong ;   et al.
2013-10-17
Antibodies Directed Against Amyloid-beta Peptide And Methods Using Same
App 20130236451 - ROSENTHAL; Arnon ;   et al.
2013-09-12
Engineered Polypeptide Conjugates And Methods For Making Thereof Using Transglutaminase
App 20130230543 - Pons; Jaume ;   et al.
2013-09-05
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20130216535 - Zeller; Joerg ;   et al.
2013-08-22
Heterodimeric Proteins And Methods For Producing And Purifying Them
App 20130115208 - Ho; Wei-Hsien ;   et al.
2013-05-09
Antibodies directed against amyloid-beta peptide and methods using same
Grant 8,425,905 - Rosenthal , et al. April 23, 2
2013-04-23
Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9
Grant 8,426,363 - Liang , et al. April 23, 2
2013-04-23
Antibodies Specific For Dkk-1 And Their Uses
App 20130071921 - PARALKAR; Vishwas Madhav ;   et al.
2013-03-21
Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibody
Grant 8,399,646 - Liang , et al. March 19, 2
2013-03-19
Antibodies directed against amyloid-beta peptide and methods using same
Grant 8,398,978 - Rosenthal , et al. March 19, 2
2013-03-19
Antibodies specific for DKK-1 and their uses
Grant 8,338,576 - Paralkar , et al. December 25, 2
2012-12-25
Antibodies Directed Against Amyloid-beta Peptide And Methods Using Same
App 20120269805 - Rosenthal; Arnon ;   et al.
2012-10-25
Polynucleotides encoding antibodies directed against amyloid-beta peptide
Grant 8,268,593 - Rosenthal , et al. September 18, 2
2012-09-18
Pcsk9 Antagonists
App 20120015435 - Liang; Hong ;   et al.
2012-01-19
Pcsk9 Antagonists
App 20120014951 - Liang; Hong ;   et al.
2012-01-19
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20120009192 - Zeller; Joerg ;   et al.
2012-01-12
Anti-NGF antibodies and methods using same
Grant 8,088,384 - Pons , et al. January 3, 2
2012-01-03
Isolated antibody which specifically binds to PCSK9
Grant 8,080,243 - Liang , et al. December 20, 2
2011-12-20
Agonist Anti-trkc Antibodies And Methods Using Same
App 20110281348 - Pons; Jaume
2011-11-17
Antibodies with pH Dependent Antigen Binding
App 20110229489 - Pons; Jaume ;   et al.
2011-09-22
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
Grant 8,007,794 - Zeller , et al. August 30, 2
2011-08-30
Agonist anti-trkC antibodies and methods using same
Grant 7,968,690 - Pons June 28, 2
2011-06-28
Antibodies directed against amyloid-beta peptide
Grant 7,927,594 - Rosenthal , et al. April 19, 2
2011-04-19
Antibodies Directed Against Amyloid-beta Peptide And Methods Using Same
App 20110044985 - Rosenthal; Arnon ;   et al.
2011-02-24
Polynucleotides Encoding Antibodies Directed Against Amyloid-beta Peptide
App 20110008834 - ROSENTHAL; ARNON ;   et al.
2011-01-13
Antibodies Specific For Dkk-1 And Their Uses
App 20100291076 - Paralkar; Vishwas Madhav ;   et al.
2010-11-18
Antibodies directed against amyloid-beta peptide and methods using same
Grant 7,807,165 - Rosenthal , et al. October 5, 2
2010-10-05
Antibodies directed against amyloid-beta peptide and nucleic acids encoding same
Grant 7,763,250 - Rosenthal , et al. July 27, 2
2010-07-27
Anti-NGF Antibodies and Methods Using Same
App 20100111970 - Pons; Jaume ;   et al.
2010-05-06
Pcsk9 Antagonists
App 20100068199 - Liang; Hong ;   et al.
2010-03-18
Anti-NGF antibodies and methods using same
Grant 7,655,232 - Pons , et al. February 2, 2
2010-02-02
Antagonist Antibodies Directed Against Calcitonin Gene-related Peptide And Methods Using Same
App 20090220489 - Zeller; Joerg ;   et al.
2009-09-03
Methods Of Treating Obesity Or Diabetes Using Nt-4/5
App 20090203610 - Rosenthal; Arnon ;   et al.
2009-08-13
Agonist anti-trkc antibodies and methods using same
App 20090202526 - Pons; Jaume
2009-08-13
Anti-NGF antibodies and methods using same
Grant 7,449,616 - Pons , et al. November 11, 2
2008-11-11
Anti-NGF antibodies and methods using same
App 20070212357 - Pons; Jaume ;   et al.
2007-09-13
Antibodies directed against amyloid-beta peptide and methods using same
App 20060292152 - Rosenthal; Arnon ;   et al.
2006-12-28
Antibodies directed against amyloid-beta peptide and methods using same
App 20060057701 - Rosenthal; Arnon ;   et al.
2006-03-16
Antibodies directed against amyloid-beta peptide and methods using same
App 20060057702 - Rosenthal; Arnon ;   et al.
2006-03-16
Methods of treating obesity or diabetes using NT-4/5
App 20050209148 - Rosenthal, Arnon ;   et al.
2005-09-22
Anti-NGF antibodies and methods using same
App 20040237124 - Pons, Jaume ;   et al.
2004-11-25
Company Registrations
SEC0001816977Pons Jaume

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed